Abstract
Despite the improvements in the therapeutic options and increasing significance of sequential strategies for advanced gastric cancer (AGC), the prognosis remains poor. Takahari et al previously reported that performance status (PS) ≥1, not receiving gastrectomy, the number of metastatic sites ≥2 and high serum ALP level are associated with poor prognosis and proposed a JCOG prognostic index by analyzing patients enrolled in clinical trials. However, the suitability assessment and utility of the JCOG prognostic index in real-world patients with AGC were unknown.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
